EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial

Leen D'hoore, Peter Germonpré, Bert Rinia, Leonard Caeyers, Nancy Stevens, Costantino Balestra

Diving and Hyperbaric Medicine Journal · 2025

DOI: 10.28920/dhm55.2.104-113 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diving and Hyperbaric Medicine Journal, 2025. Verfasst von Leen D'hoore und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Hyperbaric Oxygen Therapy, Queen Astrid Military Hospital, Brussels, Belgium. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, COVID-19, Cognition. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long COVID syndrome is a major health issue. Multiple treatments have been proposed but efficacy is inadequately investigated. Hyperbaric oxygen therapy (HBOT) has been promoted based on a small number of publications. As there is potential for a placebo effect and the financial cost of HBOT is high, we sought to investigate the effects of HBOT in Long COVID in a randomised trial.

Methods

We randomised 101 patients into four treatment groups, receiving 10 sessions of oxygen ‘treatment’ inside a pressure chamber, according to one of four modalities: A – 100% oxygen at 253 kPa (2.5 atmospheres absolute); B – 40% oxygen at 253 kPa; C – 100% oxygen at 101.3 kPa (1 atmosphere absolute); D – 21% oxygen at 101.3 kPa. Groups B and C thus received a similar effective oxygen dose of 101.3 kPa. Quality of life symptom scores (Visual Analogue Scale; EQ-5D-5L, C19-YRSm), a 6-minute walking test and five neurocognitive tests were administered before and after the treatment series. At three months post-treatment, a telephone questionnaire probed for lasting effects.

Results

All groups were comparable with regards to demographics, Long COVID symptoms and severity. After treatment, there were no significant differences in subjective symptoms, functional scores, and cognitive performance between any groups. The response to treatment was highly variable, with some patients in even the ‘placebo’ group D reporting a significant improvement in their well-being. This was not reflected in any objective outcome scores. No subgroups of patients responded better to any of the treatments.

Conclusions

There was no significant effect from different doses of oxygen in a hyperbaric chamber. It is possible that the very modest improvements reported in other studies were due to a placebo effect. Claims that HBOT has a significant effect on Long COVID need further investigation before indiscriminately prescribing or promoting HBOT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperbaric OxygenationCOVID-19CognitionHumansMaleFemaleMiddle AgedProspective StudiesDouble-Blind MethodQuality of LifeAdultAgedTreatment OutcomeWalk TestPost-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

COVID-19Hyperbaric oxygenRandomised controlled trialSARS-CoV-2

Autor:innen und Institutionen

  • Centre for Hyperbaric Oxygen Therapy, Queen Astrid Military Hospital, Brussels, Belgium.
  • DAN Europe Research Division, Roseto, Italy and Brussels, Belgium.
  • Corresponding author: Dr Peter Germonpré, Queen Astrid Military Hospital, Bruynstraat 1, B-1120 Brussels, Belgium, ORCiD: 0000-0003-2481-7376, peter.germonpre@mil.be.
  • Environmental, Occupational, Aging (Integrative) Physiology Laboratory, Haute Ecole Bruxelles-Brabant (HE2B), Brussels, Belgium.
  • Motor Sciences Department, Physical Activity Teaching Unit, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Zitieren

APA

D'hoore, L., Germonpré, P., Rinia, B., Caeyers, L., Stevens, N., & Balestra, C. (2025). Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial. Diving and Hyperbaric Medicine Journal. https://doi.org/10.28920/dhm55.2.104-113

Vancouver

D'hoore L, Germonpré P, Rinia B, Caeyers L, Stevens N, Balestra C. Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial. Diving and Hyperbaric Medicine Journal. 2025. doi:10.28920/dhm55.2.104-113

BibTeX
@article{Dhoore2025,
  author = {D'hoore, Leen and Germonpré, Peter and Rinia, Bert and Caeyers, Leonard and Stevens, Nancy and Balestra, Costantino},
  title = {Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial},
  journal = {Diving and Hyperbaric Medicine Journal},
  year = {2025},
  doi = {10.28920/dhm55.2.104-113}
}
Kostenlos starten →